Envista Holdings Corp

NVSTNEW YORK STOCK EXCHANGE, INC.

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,300 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Envista Holdings Corp.